19/58
1.6 / 5 stars
All 58 Win/Lose results and 62 gray no-data contests shown below
ALEC Roast Me summary
Alector, Inc. (ALEC). Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth No data.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth No data.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth No data.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth No data.
Trailing 1 year (4 quarters): 3 wins, 5 losses, 4 no dataLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/2 |
LoseALEC / S&P -6.51% / 15.20% |
LoseALEC / S&P -82.91% / 15.00% |
No dataALEC / S&P / 50.40% |
| 2026-Q11/2 |
WinALEC / S&P 37.82% / -4.33% |
LoseALEC / S&P -79.15% / 11.30% |
No dataALEC / S&P / 27.70% |
| 2025-Q40/2 |
LoseALEC / S&P -47.30% / 2.65% |
LoseALEC / S&P -79.07% / 9.00% |
No dataALEC / S&P / 13.40% |
| 2025-Q32/2 |
WinALEC / S&P 111.43% / 8.12% |
WinALEC / S&P 12.26% / 4.61% |
No dataALEC / S&P / 13.45% |
| 2025-Q22/2 |
WinALEC / S&P 13.82% / 10.94% |
WinALEC / S&P 46.78% / 4.83% |
No dataALEC / S&P / 10.63% |
| 2025-Q10/2 |
LoseALEC / S&P -34.92% / -4.27% |
LoseALEC / S&P -8.37% / 4.98% |
No dataALEC / S&P / 10.57% |
| 2024-Q40/2 |
LoseALEC / S&P -59.44% / 2.41% |
LoseALEC / S&P 3.60% / 5.25% |
No dataALEC / S&P / 6.15% |
| 2024-Q30/2 |
LoseALEC / S&P 2.64% / 5.89% |
LoseALEC / S&P -36.14% / 5.89% |
No dataALEC / S&P / 6.11% |
| 2024-Q20/2 |
LoseALEC / S&P -24.58% / 4.28% |
LoseALEC / S&P -45.84% / 5.38% |
No dataALEC / S&P / 5.12% |
| 2024-Q10/2 |
LoseALEC / S&P -24.56% / 10.56% |
LoseALEC / S&P -23.30% / 5.71% |
No dataALEC / S&P / 5.59% |
| 2023-Q41/2 |
WinALEC / S&P 23.15% / 11.69% |
LoseALEC / S&P -27.36% / 6.81% |
No dataALEC / S&P / 7.78% |
| 2023-Q31/2 |
WinALEC / S&P 7.82% / -3.27% |
LoseALEC / S&P -27.68% / 7.52% |
No dataALEC / S&P / -5.03% |
| 2023-Q20/3 |
LoseALEC / S&P -2.91% / 8.74% |
LoseALEC / S&P -66.06% / 9.50% |
LoseALEC / S&P -543.59% / -8.57% |
| 2023-Q10/2 |
LoseALEC / S&P -32.94% / 7.50% |
LoseALEC / S&P -44.74% / 10.77% |
No dataALEC / S&P / -15.69% |
| 2022-Q40/2 |
LoseALEC / S&P -2.43% / 7.56% |
LoseALEC / S&P -35.48% / 11.88% |
No dataALEC / S&P / -17.99% |
| 2022-Q30/2 |
LoseALEC / S&P -6.89% / -4.88% |
LoseALEC / S&P -32.72% / 13.47% |
No dataALEC / S&P / -1.41% |
| 2022-Q21/2 |
LoseALEC / S&P -28.70% / -16.10% |
WinALEC / S&P 1303.00% / 13.71% |
No dataALEC / S&P / 11.04% |
| 2022-Q11/2 |
LoseALEC / S&P -30.99% / -4.60% |
WinALEC / S&P 1161.01% / 15.97% |
No dataALEC / S&P / 42.23% |
| 2021-Q41/2 |
LoseALEC / S&P -9.51% / 11.03% |
WinALEC / S&P 881.54% / 15.00% |
No dataALEC / S&P / 96.40% |
| 2021-Q32/2 |
WinALEC / S&P 9.55% / 0.58% |
WinALEC / S&P 789.80% / 10.77% |
No dataALEC / S&P / 69.42% |
| 2021-Q21/2 |
LoseALEC / S&P 3.43% / 8.55% |
WinALEC / S&P 12.59% / 6.58% |
No dataALEC / S&P / 51.81% |
| 2021-Q11/2 |
WinALEC / S&P 33.11% / 6.17% |
LoseALEC / S&P -20.84% / -1.06% |
No dataALEC / S&P / 7.39% |
| 2020-Q42/2 |
WinALEC / S&P 43.62% / 12.15% |
WinALEC / S&P -0.57% / -3.72% |
No dataALEC / S&P / -33.42% |
| 2020-Q30/2 |
LoseALEC / S&P -56.89% / 8.93% |
LoseALEC / S&P -8.69% / -2.04% |
No dataALEC / S&P / -27.10% |
| 2020-Q20/2 |
LoseALEC / S&P 1.28% / 20.54% |
LoseALEC / S&P -32.42% / -0.46% |
No dataALEC / S&P / -27.11% |
| 2020-Q11/2 |
WinALEC / S&P 40.05% / -19.60% |
LoseALEC / S&P -19.66% / 3.47% |
No dataALEC / S&P / -14.75% |
| 2019-Q41/2 |
WinALEC / S&P 19.49% / 9.07% |
LoseALEC / S&P -22.86% / 5.36% |
No dataALEC / S&P / 2.99% |
| 2019-Q30/1 |
LoseALEC / S&P -24.11% / 1.70% |
No dataALEC / S&P / 5.02% |
No dataALEC / S&P / 0.21% |
| 2019-Q20/1 |
LoseALEC / S&P 1.50% / 4.30% |
No dataALEC / S&P / 6.64% |
No dataALEC / S&P / 8.65% |
| 2019-Q10/0 |
No dataALEC / S&P / 13.65% |
No dataALEC / S&P / 8.12% |
No dataALEC / S&P / 14.29% |
| 2018-Q41/1 |
No dataALEC / S&P / -13.52% |
WinALEC / S&P 857.80% / 9.05% |
No dataALEC / S&P / 18.23% |
| 2018-Q30/0 |
No dataALEC / S&P / 7.71% |
No dataALEC / S&P / 10.21% |
No dataALEC / S&P / 19.06% |
| 2018-Q20/0 |
No dataALEC / S&P / 3.43% |
No dataALEC / S&P / 9.03% |
No dataALEC / S&P / 14.46% |
| 2018-Q10/0 |
No dataALEC / S&P / -0.76% |
No dataALEC / S&P / 7.68% |
No dataALEC / S&P / 12.46% |
| 2017-Q40/0 |
No dataALEC / S&P / 6.64% |
No dataALEC / S&P / 7.03% |
No dataALEC / S&P / 13.82% |
| 2017-Q30/0 |
No dataALEC / S&P / 4.48% |
No dataALEC / S&P / 5.68% |
No dataALEC / S&P / 17.57% |
| 2017-Q20/0 |
No dataALEC / S&P / 3.09% |
No dataALEC / S&P / 4.83% |
No dataALEC / S&P / 17.74% |
| 2017-Q10/0 |
No dataALEC / S&P / 6.07% |
No dataALEC / S&P / 3.67% |
No dataALEC / S&P / 13.32% |
| 2016-Q40/0 |
No dataALEC / S&P / 3.82% |
No dataALEC / S&P / 2.09% |
No dataALEC / S&P / 7.05% |
| 2016-Q30/0 |
No dataALEC / S&P / 3.85% |
No dataALEC / S&P / 0.20% |
No dataALEC / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | ALEC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -0.43% | 20.78% |
| Annualized return | -0.43% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | ALEC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -91.39% | 83.14% |
| Annualized return | -38.76% | 12.86% |
10Y · 2019-02-07 to 2026-08-28
| Metric | ALEC total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -87.06% | 319.30% |
| Annualized return | -18.49% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |